PracticeLink Magazine

FALL 2013

The career development quarterly for physicians of all specialties, PracticeLink Magazine provides readers with feature articles, compensation stats, helpful job search tips—as well as recruitment ads from organizations across the U.S.

Issue link:

Contents of this Issue


Page 14 of 91

Tech Notes The latest in gadgets and apps for physicians BY DAVID GEER Physician entrepreneurs bring products to market These physicians had great ideas—and turned them into viable companies and saleable products that improve patient experiences and outcomes. Inform 99.7 percent of women as to whether they have pre-cancer in the breast? Genuinely block the pain sensation when a child receives a shot? These would be great leaps forward in the eyes of each of these patient groups—and the physicians in this issue's Tech Notes column have combined their medical skills with entrepreneurial spirit to make great strides in these areas. Confrming pre-cancer The MASCT System and ForeCYTE Breast Health Test use infinitesimal samples to determine breast cancer risk. T he end game for steven quay, M.D.'s, latest of six biotech companies was to build on the work of Dr. George Papanicolaou of Pap Smear fame who tested breast secretions. Whereas Papanicolaou could only successfully retrieve test samples from 18 percent of his patients, Quay was eager to test a full 100 percent of samples for pre-cancer. "I took a leap of faith. What I started to realize was that the size of the specimen I needed to see pre-cancer cells under the microscope was actually a smaller amount of liquid than the human eye can see," Quay says. Quay developed and now markets the Atossa Genet- ics MASCT System and the ForeCYTE Breast Health Test ( to effectively collect and test the infnitesimal samples. "I developed a special flter that can pull tiny samples out of the nipple by capillary action. I can actually detect as little as seven Pico liters," Quay says. From those, Quay's lab can confrm the presence of atypical hyperplasia of the cells where the risk of cancer is signifcantly higher than with normal cells. Kathryn Wood, M.D., FACOG, an OB/GYN and medical director of her practice Dermalase, incorporates the Atossa Genetics MASCT medical device and the ForeCYTE Breast Health Test into her practice routinely. "It really helps me get a better risk assessment on each This device can extract individual patient," Wood says. tiny samples of liquid Prior to the arrival of the MASCT from a breast to help device and accompanying test, determine cancer risk. Wood used a HALO machine, which is much less comfortable for the patient than the MASCT device. The MASCT device, a screening tool, is quick and effective with a test result turn time of about two weeks, according to Wood. The pathologist's results combine the ForeCYTE Breast Health Test results with the patient's family and personal history and use the Gail Model to Continued FALL 2013 | 15

Articles in this issue

Links on this page

Archives of this issue

view archives of PracticeLink Magazine - FALL 2013